Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202)

BACKGROUND: Apatinib was shown to improve the survival of Chinese patients with refractory metastatic gastric cancer (mGC). As an orally administered drug, it has been widely used in elderly patients because the dosing schedule can be adjusted flexibly. However, data on the efficacy and safety of ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiang, Zhong, Diansheng, Zhang, Junping, Du, Nan, Ren, Yuchuan, Gao, Jinghua, Liu, Likun, Yu, Junyan, Li, Xiaomei, Ma, Liwen, Zang, Aimin, Yang, Mudan, Zhang, Yan, Guo, Jun, Liu, Zheng, Fu, Zhanzhao, Jia, Junmei, Diao, Jianfeng, Fan, Zaiwen, Song, Xiang, Li, Guozhong, Wang, Huaqing, Bai, Chunmei, Guan, Mei, Ren, Xiubao, Zhang, Ruixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459208/
https://www.ncbi.nlm.nih.gov/pubmed/36092345
http://dx.doi.org/10.21037/jgo-22-727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459208/
https://www.ncbi.nlm.nih.gov/pubmed/36092345
http://dx.doi.org/10.21037/jgo-22-727

Ejemplares similares